Anatara Historical Cash Flow

ANR Stock

0.06 0 1.72%

Analysis of Anatara Lifesciences cash flow over time is an excellent tool to project Anatara Lifesciences future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 3.8 or Total Cash From Financing Activities of 2.5 M as it is a great indicator of Anatara Lifesciences ability to facilitate future growth, repay debt on time or pay out dividends.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Anatara Lifesciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Anatara Lifesciences is a good buy for the upcoming year.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anatara Lifesciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Anatara Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Anatara balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Anatara's non-liquid assets can be easily converted into cash.

Anatara Lifesciences Cash Flow Chart

At this time, Anatara Lifesciences' Total Cash From Financing Activities is comparatively stable compared to the past year. End Period Cash Flow is likely to gain to about 1.8 M in 2024, whereas Free Cash Flow is likely to drop (1.3 M) in 2024.

Capital Expenditures End Period Cash Flow Begin Period Cash Flow Stock Based Compensation Issuance Of Capital Stock

Capital Expenditures

Capital Expenditures are funds used by Anatara Lifesciences to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Anatara Lifesciences operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Most accounts from Anatara Lifesciences' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Anatara Lifesciences current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anatara Lifesciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Anatara Lifesciences cash flow statement Correlations

	Capital Expenditures	End Period Cash Flow	Change In Cash	Free Cash Flow	Change In Working Capital	Begin Period Cash Flow	Other Non Cash Items	Change To Account Receivables	Net Income	Sale Purchase Of Stock	Investments	Net Borrowings	Depreciation	Change To Operating Activities	Change To Netincome	Change To Liabilities	Change To Inventory	Stock Based Compensation	Issuance Of Capital Stock
Capital Expenditures		0.56	-0.06	-0.45	-0.62	0.62	-0.28	-0.61	-0.21	-0.15	0.14	0.11	0.22	0.18	0.08	-0.2	0.0	0.32	0.35
End Period Cash Flow	0.56		0.5	-0.3	-0.46	0.46	-0.29	-0.43	-0.11	-0.45	0.51	-0.13	-0.07	0.03	0.23	-0.42	0.32	0.25	0.26
Change In Cash	-0.06	0.5		0.44	0.13	-0.53	-0.18	0.13	0.49	-0.03	0.25	0.11	-0.36	-0.08	0.71	-0.59	0.5	0.34	0.15
Free Cash Flow	-0.45	-0.3	0.44		0.24	-0.74	-0.08	0.24	0.92	0.67	-0.61	0.54	-0.33	0.09	0.42	0.13	-0.13	0.21	0.12
Change In Working Capital	-0.62	-0.46	0.13	0.24		-0.59	0.36	0.99	-0.07	-0.02	0.05	-0.09	-0.1	-0.68	0.12	-0.06	0.4	-0.1	-0.15
Begin Period Cash Flow	0.62	0.46	-0.53	-0.74	-0.59		-0.08	-0.56	-0.6	-0.4	0.23	-0.21	0.34	0.11	-0.48	0.18	-0.19	-0.07	0.13
Other Non Cash Items	-0.28	-0.29	-0.18	-0.08	0.36	-0.08		0.32	-0.28	-0.08	-0.13	0.07	0.41	-0.58	-0.12	0.31	0.09	-0.01	0.15
Change To Account Receivables	-0.61	-0.43	0.13	0.24	0.99	-0.56	0.32		-0.07	-0.03	0.04	-0.08	-0.13	-0.68	0.12	-0.07	0.4	-0.1	-0.12
Net Income	-0.21	-0.11	0.49	0.92	-0.07	-0.6	-0.28	-0.07		0.68	-0.52	0.54	-0.33	0.25	0.45	-0.05	-0.09	0.23	0.14
Sale Purchase Of Stock	-0.15	-0.45	-0.03	0.67	-0.02	-0.4	-0.08	-0.03	0.68		-0.48	0.79	0.01	0.18	0.37	0.17	-0.14	0.37	0.29
Investments	0.14	0.51	0.25	-0.61	0.05	0.23	-0.13	0.04	-0.52	-0.48		-0.49	0.01	-0.28	0.07	-0.63	0.69	-0.1	-0.21
Net Borrowings	0.11	-0.13	0.11	0.54	-0.09	-0.21	0.07	-0.08	0.54	0.79	-0.49		0.05	0.04	0.6	0.15	-0.09	0.78	0.81
Depreciation	0.22	-0.07	-0.36	-0.33	-0.1	0.34	0.41	-0.13	-0.33	0.01	0.01	0.05		-0.28	0.03	0.07	0.11	0.25	0.07
Change To Operating Activities	0.18	0.03	-0.08	0.09	-0.68	0.11	-0.58	-0.68	0.25	0.18	-0.28	0.04	-0.28		-0.1	0.2	-0.66	-0.04	-0.12
Change To Netincome	0.08	0.23	0.71	0.42	0.12	-0.48	-0.12	0.12	0.45	0.37	0.07	0.6	0.03	-0.1		-0.51	0.47	0.84	0.57
Change To Liabilities	-0.2	-0.42	-0.59	0.13	-0.06	0.18	0.31	-0.07	-0.05	0.17	-0.63	0.15	0.07	0.2	-0.51		-0.83	-0.14	0.04
Change To Inventory	0.0	0.32	0.5	-0.13	0.4	-0.19	0.09	0.4	-0.09	-0.14	0.69	-0.09	0.11	-0.66	0.47	-0.83		0.17	0.04
Stock Based Compensation	0.32	0.25	0.34	0.21	-0.1	-0.07	-0.01	-0.1	0.23	0.37	-0.1	0.78	0.25	-0.04	0.84	-0.14	0.17		0.85
Issuance Of Capital Stock	0.35	0.26	0.15	0.12	-0.15	0.13	0.15	-0.12	0.14	0.29	-0.21	0.81	0.07	-0.12	0.57	0.04	0.04	0.85

Click cells to compare fundamentals

Anatara Lifesciences Account Relationship Matchups

Anatara Lifesciences cash flow statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Other Cashflows From Financing Activities	4.0M	(514.0)	(17.4K)	(18.2K)	50K	47.5K
End Period Cash Flow	2.7M	3.4M	1.1M	351.2K	982.1K	1.8M
Change In Cash	1.3M	749.7K	(2.3M)	(769.0K)	630.9K	662.5K
Free Cash Flow	(2.7M)	(2.1M)	(2.2M)	(2.3M)	(1.2M)	(1.3M)
Change In Working Capital	318.2K	(225.8K)	199.9K	(330.4K)	343.2K	360.4K
Begin Period Cash Flow	1.4M	2.7M	3.4M	1.1M	351.2K	333.6K
Other Non Cash Items	72.0K	272.7K	(106.4K)	442.9K	(170.4K)	(161.9K)
Total Cash From Operating Activities	(2.7M)	(2.1M)	(2.2M)	(2.3M)	(1.2M)	(1.3M)
Change To Account Receivables	265.7K	(142.2K)	264.0K	(495.6K)	333.0K	349.6K
Net Income	(3.4M)	(2.0M)	(2.5M)	(2.0M)	(1.5M)	(1.5M)
Investments	4.1M	(4.0K)	(50K)	(1.7K)	50K	52.5K
Total Cashflows From Investing Activities	4.0M	(4.0K)	(56.6K)	(1.7K)	(2.0K)	(2.1K)
Depreciation	16.1K	6.3K	24.7K	24.8K	2.5K	2.3K
Change To Operating Activities	4.7K	(6.7K)	(30.6K)	(7.9K)	(7.1K)	(7.5K)
Change To Netincome	305.5K	117.9K	74.8K	70.9K	63.8K	60.6K
Change To Liabilities	47.8K	(76.9K)	(33.5K)	173.1K	155.8K	163.6K
Change To Inventory	(931.9K)	732.8K	64.1K	(165.2K)	(190.0K)	(180.5K)
Stock Based Compensation	305.7K	117.6K	71.5K	54.6K	28.6K	27.2K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Anatara Stock Analysis

When running Anatara Lifesciences' price analysis, check to measure Anatara Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anatara Lifesciences is operating at the current time. Most of Anatara Lifesciences' value examination focuses on studying past and present price action to predict the probability of Anatara Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anatara Lifesciences' price. Additionally, you may evaluate how the addition of Anatara Lifesciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC